Blackstone Inc

• Blackstone shares experienced sharp volatility and bargain hunting ahead of earnings. • The firm maintains strong fee-related earnings and record assets under management. • Analysts rate the stock as Buy with an average price target.

• Blackstone exited ZO Skin Health for $1.5 billion to Galderma. • The firm is expanding its $200 billion data center empire. • Blackstone reports an annual revenue of $14.87 billion.

• Macroeconomic headwinds and rising Treasury yields pressured alternative asset managers. • Analysts trimmed price targets ahead of the upcoming earnings announcement. • Blackstone reports an annual revenue of $14.87B and net profit of $3.02B.

• Blackstone faced selling pressure from rising Treasury yields and hawkish central bank messaging. • Executive leadership transitions within private equity operations temporarily influenced market sentiment. • Technical indicators show a sell signal with an RSI of 27.600.

• Blackstone reported preliminary realization revenues exceeding three hundred fifty million dollars. • Slower asset sales triggered analyst earnings estimate revisions and institutional selling. • High interest rates and constrained dealmaking created sector-wide headwinds for Blackstone.

• Blackstone shares faced downward pressure amid broader macroeconomic uncertainties and shifting market sentiment. • Short-term profit taking and portfolio rebalancing contributed to intraday equity momentum. • Analysts maintain an average price target of $147.94 with multiple Buy ratings.